VIENNA, AUSTRIA (UroToday.com) - The study goal was to evaluate health related quality of life (HRQOL) after salvage high intensity focused ultrasound (HIFU) for locally radio-recurrent prostate cancer (CaP).
VIENNA, AUSTRIA (UroToday.com) - This group's objective was to examine the prognosis of patients who experienced biochemical progression (BCR) after adjuvant radiotherapy (aRT) for prostate cancer (CaP).
VIENNA, AUSTRIA (UroToday.com) - This was a collaborative study among European institutions. Since only about one-third of prostate cancer patients with adverse pathology on radical prostatectomy (RP) benefit from adjuvant radiotherapy (aRT), many urologists choose to monitor sensitive PSA tests and administer early salvage radiotherapy (eSRT) instead.
VIENNA, AUSTRIA (UroToday.com) - The intent of this study was to improve upon existing nomograms to predict the likelihood of prostate cancer (CaP) recurrence following radical prostatectomy by integrating biomarkers.